Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Rougned Odor

Latest On Rangers’ Infield

By | at

Elvis Andrus has been the Rangers’ everyday shortstop since he debuted in 2009, but those days are coming to an end. He’ll take on a utility role in 2021, while Isiah Kiner-Falefa will have an opportunity to become the Rangers’ starting shortstop, Evan Grant of the Dallas Morning News reports.

The 32-year-old Andrus has thrived at times, which led the Rangers to give him an eight-year, $120MM extension that kicked in during 2015, but his production has tumbled in recent seasons. Dating back to 2018, Andrus has batted a dismal .260/.306/.378 (73 wRC+) with 21 home runs and 39 stolen bases across 1,187 plate appearances. He’ll now play multiple positions in the rebuilding Rangers’ infield, where they have questions everywhere, including at second base. Rougned Odor has been Andrus’ longtime double-play partner, but his starting job also isn’t set in stone, Grant tweets.

The Rangers may want to jettison Andrus and Odor in trades, but it would be difficult to find takers for either. Andrus has another two years and $28MM left on his contract, while Odor’s deal includes two more seasons at $27MM (including a $3MM buyout for 2023). Those are steep commitments for players who have offered poor production for multiple seasons in a row. In Andrus’ case, Grant notes he has 10-and-5 rights, and his $15MM club option for 2023 would turn into a player option in the event of a trade. With those facts in mind, it will be that much more of a challenge for the Rangers to trade him.

Kiner-Falefa, like Andrus and Odor, has not hit much in the past few seasons. He came into the league in 2018 and has since batted .260/.319/.351 (75 wRC+) with eight homers and 18 steals in 846 PA. Kiner-Falefa has seen action at a handful of positions, though, and he even earned an American League Gold Glove Award for the work he did at third base in 2020. The Rangers are hopeful the 25-year-old’s value will increase at short, though it’s unclear who will start for the team at third. It’s “likely” they’ll pick up a third baseman on a one-year deal in free agency to help bridge the gap to prospect Josh Jung, according to Grant.

Rangers’ Jon Daniels On Rotation, Infield

By | at

On the heels of another disappointing season, one that saw the Rangers finish 22-38 and extend their playoff drought to four years, general manager Jon Daniels spoke to media, including Jeff Wilson of the Fort Worth Star-Telegram and TR Sullivan of MLB.com.

With their starters having ended 2020 with the majors’ seventh-worst ERA (5.32), Daniels said the Rangers are interested in bringing in a veteran rotation member during the offseason. The only starter on the team who provided high-end production across a large number of innings in 2020 was Lance Lynn, who’s only signed for another year and whom the Rangers could trade for a solid haul. Kyle Cody gave the team outstanding results, albeit over a small number of innings, and the Rangers traded Mike Minor to the A’s before the Aug. 31 deadline.

Texas has Lynn, Cody, Jordan Lyles and Kyle Gibson (he and Lyles had rough years) among their most proven starters going into next season. Two-time Cy Young winner Corey Kluber’s still on the roster, but as someone who missed nearly the entire season with shoulder troubles, he seems like a shoo-in to be bought out for $1MM (as opposed to guaranteeing him $18MM).

Turning to the offensive side, the Rangers aren’t planning on gifting starting spots to second baseman Rougned Odor or shortstop Elvis Andrus going forward, per Daniels. Frankly, neither player deserves one. Both players could be trade candidates in the coming months, and if that’s the case, the Daniels-led Rangers are confident they won’t have to eat any of their contracts. That may be wishful thinking, as Odor has two more seasons and $27MM left on his contract, while Andrus has $28MM over two years remaining.

Odor has three seasons of two-plus fWAR in his past, and he’s someone the Rangers signed to a six-year, $49.5MM guarantee entering 2017, but his production has been terrible of late. Despite 10 home runs in 148 plate appearances, the 26-year-old ended 2020 with a .167/.209/.413 line. His 51 wRC+ ranked second to last among 223 hitters who racked up at least 140 PA this season.

Andrus was even worse than Odor this year, as he logged a 48 wRC+ in 111 trips to the plate. Like Odor, Andrus looked like a cornerstone for the Rangers in his earlier days, which is why they extended him to an eight-year, $120MM contract in early 2013. However, his production has fallen flat over the past few seasons.

Rangers Place Shin-Soo Choo On Injured List, Activate Rougned Odor

By and | at

The Rangers placed outfielder Shin-Soo Choo on the 10-day injured list due to a right hand sprain, the team announced.  Choo’s placement is retroactive to Setpember 8.  Rougned Odor will take Choo’s spot on the active roster, as the second baseman has recovered from an eye infection and been activated from his own 10-day IL stint.

With the Rangers at 14-27 and well out of contention, it seems eminently possible that we’ve seen the last of Choo this season. This injury could also spell the end of Choo’s Rangers tenure, as he’s due to reach free agency in the winter.

Choo, now 38, signed a seven-year, $130MM contract with the Rangers before the 2014 season. He was coming off strong offensive runs with the Indians and Reds at the time, and has continued as an above-average batter with the Rangers. The switch-hitting Choo has only produced 8.7 fWAR in Texas, though, largely owing to an inability to contribute much value on defense. And 2020 has been Choo’s worst season as the plate as a Ranger, as he has hit a measly .229/.318/.395 in 126 PA. Regardless of whether Choo plays again this year, he’ll have to decide in the offseason if he’s going to call it a career or seek another deal.

Rangers Make Series Of Moves

By | at

The Rangers have made a series of moves, per a team announcement. The club reinstated shortstop Elvis Andrus and reliever Brett Martin from the 10-day injured list, placed second baseman Rougned Odor on the 10-day IL with an eye infection, selected outfielder Eli White and recalled infielder Anderson Tejeda.

Andrus is returning after landing on the IL on Aug. 20 with a lower back strain. The 31-year-old hit an ugly .184/.244/.250 in 82 plate appearances before then, and he won’t have his double-play partner, Odor, around upon his return. Odor, like Andrus, has gotten off to a difficult start this year. His IL placement is retroactive to Aug. 28.

White, 26, looks to be in line for his major league debut four years after the Athletics chose him in the 11th round of the 2016 draft. He joined the Rangers in the division rivals’ pre-2019 trade that Jurickson Profar and Emilio Pagan headlined. White reached the Triple-A level for the first time in his initial season in the Texas organization, but he only managed a .253/.337/.418 line with 14 home runs and 14 stolen bases across 499 plate appearances. He ranked as FanGraphs’ 37th-best Rangers prospect before the current campaign.

AL Injury Notes: Twins, Jays, Kennedy, Hernandez, Odor

By | at

Some notes on prominent injury situations around the American League:

  • Twins’ manager Rocco Baldelli provided encouraging updates on a trio of injured players, via Do-Hyoung Park of MLB.com (Twitter links). Star third baseman Josh Donaldson and center fielder Byron Buxton are seemingly nearing their returns, with each scheduled to play in an intrasquad game at the team’s alternate training site this afternoon. Right-hander Cody Stashak is evidently a bit further behind, but he’s lining up for a bullpen session soon, Park reports. If all goes well, he could be back on the active roster shortly thereafter.
  • Blue Jays’ closer Ken Giles will throw a live batting practice session tomorrow, reports Ben Nicholson-Smith of Sportsnet (Twitter link). An impending free agent, Giles has been limited to two appearances this season by a forearm strain. Fellow right-handed reliever Jordan Romano, who looked on his way to breaking through as one of the game’s top strikeout artists before going down with a strained finger, has not yet progressed to throwing, Nicholson-Smith adds. The Toronto organization hopes he’ll be able to return this year, though.
  • Royals’ reliever Ian Kennedy is headed to the 10-day injured list with a left calf strain, the club announced. He’ll have an MRI tomorrow, reports Jeffrey Flanagan of MLB.com (Twitter link). So continues a nightmarish season for the 35-year-old, who has allowed 17 runs (14 earned) in 14 innings. 2020 is the final year of Kennedy’s five-year, $70MM contract.
  • The Red Sox are sending reliever Darwinzon Hernández to the 10-day injured list with a sprained AC joint, via Alex Speier of the Boston Globe (Twitter link). The hard-throwing southpaw missed the first three weeks of the season after testing positive for COVID-19, limiting him to three appearances. They’ve been more of the same for Hernández, who continues to rack up otherworldly strikeout totals while issuing an alarming number of walks.
  • Rougned Odor is headed to the Rangers’ 10-day injured list with an eye infection, per Evan Grant of the Dallas Morning News (Twitter link). In his stead, shortstop Elvis Andrus is returning from an IL stint of his own. The Rangers discussed an Odor deal with the Red Sox earlier today, but the underperforming second baseman will instead remain in Arlington.

Rangers, Red Sox Have Discussed Rougned Odor-Nathan Eovaldi Trade

By | at

The Rangers and Red Sox have discussed a trade that would send second baseman Rougned Odor to Boston for right-hander Nathan Eovaldi, Evan Grant of the Dallas Morning News tweets. It’s unclear whether the trade would include Texas taking on extra money or if prospects would be in the deal, according to Grant.

Odor, who’s making a prorated $9MM in 2020, is in the fourth season of a six-year, $49.5MM contract that includes a remaining $27MM. The deal also features a $13.5MM club option for 2023, but the way Odor’s career has gone, his employer’s sure to buy him out for $3MM. When Odor signed his pact in 2017, he was coming off back-to-back 2.5-fWAR seasons, but he has seldom revisited that form since then. In fact, going back to the first season of the contract, Odor has slashed a less-than-stellar .216/.281/.412 with 81 home runs, 38 stolen bases and 0.6 fWAR across 1,853 plate appearances. His 17 wRC+ this season over 86 trips to the plate ranks next to last among 224 hitters who have amassed 80-plus PA.

Eovaldi, whom the Red Sox acquired from the Rays in 2018, was one of their many standouts during their run to a World Series that year. He was on the cusp of free agency at the time, but his down-the-stretch success convinced Boston to hand him a four-year, $68MM contract during the ensuing offseason. Unfortunately for both sides, though, the move hasn’t gone well. Eovaldi, 30, missed a large portion of last season with injuries and, despite 97 mph velocity and 8.65 K/9 against 1.57 BB/9, hasn’t done well to keep runs off the board this year. Overall, he has pitched to a woeful 5.65 ERA/5.45 FIP in 102 innings since landing his big payday. He’ll be due another $34MM after this season, and his annual $17MM luxury tax bill is another negative for a Red Sox team trying to avoid the line, as Pete Abraham of the Boston Globe notes. Odor’s CBT bill comes in at a much more palatable $8.25MM.

Should this change-of-scenery swap go down, the Red Sox would be landing a potential second base starter who’s still just 26. The injury-plagued Dustin Pedroia has barely been a factor since 2018, and he may never play again because of knee issues. And his year’s primary second base options – Jose Peraza and Jonathan Arauz – have mustered weak production. Meanwhile, Eovaldi would at least give the Rangers another arm in a rotation that’s in flux. The Rangers just parted with Mike Minor in a trade with the Athletics on Monday, and it appears Lance Lynn could also move before the 3 p.m. CT deadline.

Wilmer Flores Changes Representation

By | at

Infielder Wilmer Flores has new representation. Flores, 28, will now be repped by Cesar Suarez of the Beverly Hills Sports Council, per MLB Network’s Jon Heyman. Flores’ change in representation will soon be reflected in MLBTR’s Agency Database. Flores had previously been repped by the McNamara Baseball Group.

Suarez is a former player himself, though he never reached the majors after signing with the Yankees as a 16-year-old, per his bio on the BHS Council’s website. He hails from Flores’ native Venezuela, as do other notable Suarez clients such as Rougned Odor and Salvador Perez. Heyman did not mention any specific impetus behind Flores’ decision to make a change at this time.

Flores, 28, is coming off a one-and-done year in Arizona. The utility infielder made the most of his time in the desert. After signing a one-year, $4.25MM guaranteed deal with the Diamondbacks, he appeared in 89 games, slashing a robust .314/.361/.487, good for a career-best 120 wRC+. Flores also missed more than a month of playing time after a foot contusion in late May pushed him to the injured list. Arizona declined a $6MM player option, making him a free agent for a $500K buyout instead.

When he was on the field, Flores performed. If you’re looking to poke holes in Flores’ 2019 output, a .332 BABIP is a good place to start, but Flores has long been a strong offensive contributor, so it’s not totally a smoke show. Still, career norms of a .268 BA and .277 BABIP point to some regression. Statcast credits Flores’ 2019 with a .329 xwOBA (league average is .318 xwOBA).

As for his new agent, there’s no immediate contractual work pending after Flores signed a two-year deal with the Giants this offseason. He made back the $6MM he was in line for in Arizona, only it’s spread out across two seasons. Flores will make $3MM in each of 2020 and 2021, while the Giants hold a $3.5MM option for 2022. If Flores can flourish in San Francisco, he should have the opportunity to net another major league contract either before his age-30 or age-31 season.

The Giants haven’t been all that active in free agency recently, so their signing of Flores was notable, especially since there’s not an obvious place to put the contact-oriented infielder. Veterans like Evan Longoria, Brandon Crawford, and Brandon Belt are entrenched around the infield on big-money deals that run concurrently to Flores’. There should be at-bats for Flores at second base, but he’s not alone there either, as Mauricio Dubon offers the Giants a higher ceiling with more team control as a pre-arb player, and Donovan Solano is coming off a mini-breakout of his own (.330/.360/.456 in 81 games last year). The presence of local hero Pablo Sandoval also muddies the waters for Flores – if Kung Pu Panda ends up making the team.

The potential for a Universal DH should give Flores some hope for grabbing a few extra PAs, but the Giants are actually pretty set on that front after bringing back the hugely popular Hunter Pence. Fans will be happy to see Pence’s name back on the lineup card, but even from a baseball standpoint, Pence is coming off a year when he unexpectedly put together an All-Star campaign at age-36. Pence finished the year hitting .297/.358/.552 with 18 home runs in 83 games as the Rangers’ DH. Like Flores, Pence also missed a fair amount of time due to injury. Given the ages of Longoria (34), Pence (37), Crawford (33), Belt (32), Sandoval (33) and even Solano (32), Flores is actually one of the young guys in the infield mix, despite his status as a 7-year MLB veteran. It’s not obvious where his playing time will come from, but there are many paths that lead to Flores seeing time as a regular infielder.

7 AL West Hitters Looking For Bounce-Back Years

By | at

As the season draws closer, we’ll be examining several prominent players around the majors who are hoping for bounce-back years. Let’s start with a group of well-known American League West position players whose numbers dipped dramatically in 2019…

Justin Upton, LF, Angels: The 32-year-old Upton has been terrific for the majority of his career (otherwise, the Angels wouldn’t have given him a five-year, $106MM guarantee after 2017), but last season was a nightmare. A foot injury kept Upton out until June, and his season ended prematurely in September on account of a right knee issue. When Upton was healthy enough to take the field, he batted a disappointing .215/.309/.416 with 12 home runs and a career-worst 30.5 percent strikeout rate (5 percent worse than his lifetime mark). Compared to 2018, his fly ball percentage and launch angle went way up, but his average exit velocity dropped almost 4 mph, and his hard-hit rate plummeted. The banged-up Upton was even worse in left field, where he accounted for minus-13 Defensive Runs Saved and a minus-5.2 Ultimate Zone Rating. Upton recently told Jeff Fletcher of the Orange County Register that he’s healthy and aiming for a rebound. The Angels will likely need one from him if they’re going to break a five-year playoff drought; if they get one, Upton should form a lethal offensive quartet with Mike Trout, Anthony Rendon and Shohei Ohtani.

Andrelton Simmons, SS, Angels: Like his teammate Upton, Simmons missed a significant number of games last year because of injury issues. Ankle troubles limited Simmons to 103 games, his fewest since 2012, and his effectiveness at the plate waned compared to the prior couple years. While Simmons has never been an offensive force, the defensive maven’s slightly above-average work with the bat from 2017-18 helped him combine for 10.4 fWAR in that span. Simmons only put up a .264/.309/.364 line in 424 PA last year, though he did continue to avoid strikeouts (8.7 percent), and his wizardry in the field helped him to a respectable 1.7 fWAR. However, he still finished near the bottom of the majors in several key offensive Statcast categories. For instance, Simmons’ xwOBA (.265) ranked in the bottom 2 percent of the league and fell 59 points from 2018. The ankle may have been holding Simmons back, but regardless, a return to form in 2020 would aid the Angels and the pending free agent’s bank account.

Khris Davis, DH, Athletics: Yet another injury case from 2019, Davis’ normally elite power was sapped during a season in which he fought hip, oblique and hand problems. After three straight 40-home run seasons (and four in a row in which he hit .247), he finished with a .220/.293/.387 line and 23 HRs over 533 PA. His ISO sunk like a stone, going from .302 in 2018 to .166 last year, and his hard contact went way down in the process. The 32-year-old has already been slowed by a calf injury early in camp, but indications are that it’s minor. Oakland will need that to be the case, especially considering the commitment the low-budget club made to Davis before last season. It still owes him $16.75MM on a two-year, $33.5MM contract that hasn’t worked out for the team so far.

Stephen Piscotty, RF, Athletics: The missed time theme continues. Piscotty’s 2019 ailments ranged from frightening (a melanoma on his right ear) to more conventional (knee and ankle injuries). The 29-year-old made just 93 appearances as a result, and he didn’t produce like the big-hitting, 3.0-fWAR player he was in 2018 when he did play. Piscotty hit .249/.309/.412 with 13 homers and 0.6 fWAR in 393 PA, though his hard-hit percentage and average exit velocity both increased. There may be hope for return to his career-best output, then, but Piscotty will first have to get over yet another health issue. He’s dealing with an oblique/rib cage injury that could jeopardize his status for Opening Day.

Mitch Haniger, RF, Mariners: Haniger was quietly great in 2018, but his playing time and his numbers sagged last season. He sat out 99 games after suffering a ruptured testicle at the beginning of June, didn’t play again after that and still hasn’t returned to health. Haniger just underwent his second surgery in the past few weeks – a microdiscectomy on his back – leaving it up in the air when he’ll debut in 2020. The 29-year-old is the Mariners’ best player, though, and if they can get a healthy version back sometime in 2020, he’s as logical a bounce-back candidate as anyone.

Mallex Smith, OF, Mariners: Smith looked like a quality pickup for the Mariners when they acquired him from the Rays after the 2018 campaign. At that point, the speedster was coming off a 3.5-fWAR, 40-steal showing in Tampa Bay. Smith amassed even more stolen bases in is first year in Seattle (46), but the rest of his stats tanked. The 26-year-old hit a weak .227/.300/.335 in 566 trips to the plate, while his defensive output was similarly poor (minus-12 DRS, minus-9.5 UZR).  The combination of subpar offense and defense led to a replacement-level fWAR for Smith, who also fell victim to a massive decline in batting average on balls in play. He logged an inflated .366 BABIP in ’18 and a .302 mark in that category last season, which partially explains the drastic difference in year-to-year production.

Rougned Odor, 2B, Rangers: If you’re a Rangers fan (or even part of the organization), you may be tired of Odor’s inconsistency. He has been a 2.0-plus-fWAR player three times in his career, most recently in 2018, but a replacement-level or worse performer twice. That includes last season – even though Odor walloped 30 homers, he was only able to slash .205/.283/.439 in 581 tries. Along the way, the left-handed Odor posted his worst strikeout percentage (30.6) and was eaten alive by righty pitchers, who held him to a dismal .190/.260/.417 line. If there’s a silver lining, it’s that Odor was much better in the second half of the season, ending the year with a flourish after general manager Jon Daniels expressed frustration with his production in late August. The Rangers still owe Odor $36MM through 2022, making it all the more important for the club to receive at least passable production from him.

Infield Notes: Odor, Padres, Hayes, Moncada

By | at

Rangers general manager Jon Daniels suggested last week the club could reduce beleaguered second baseman Rougned Odor’s playing time. Manager Chris Woodward was even more aggressive Thursday in saying the Rangers need better from Odor, telling TR Sullivan of MLB.com that he’s “obviously got to show some improvement.” Otherwise, the Rangers will “have to make some decisions,” Woodward said, adding: “We are willing to withstand some lack of production, but this is the big leagues. I hate to say it, but you’ve got to be good to play every day, and he knows.” Woodward believes the rest of the season will be critical for Odor, who has turned in abysmal production for the second time since 2017. Prospect Nick Solak has been eating into Odor’s playing time of late as a result. Contrary to the inexpensive Solak, Odor’s causing a sizable dent in the Texas payroll. He’ll earn a guaranteed $36MM from 2020-22, including a $3MM buyout for ’23. Finances notwithstanding, Woodward will be reluctant to continue penciling Odor into the lineup if he continues putting up bottom-of-the-barrel numbers.

  • The Padres are anticipating a heated second base competition next spring between Luis Urias and Ty France, per AJ Cassavell of MLB.com. Urias is the more hyped player of the duo, as he’s not far removed from a run as an elite prospect, but San Diego doesn’t want to simply hand him a starting job. The 22-year-old has recorded weak offensive totals since he debuted in the majors last season, having logged a .191/.302/.289 line through 202 trips to the plate, though Urias has been much more productive this month. He also laid waste to Triple-A pitching earlier this season. France, 25, has been even better this season at that level, where he has performed like one of the premier hitters in the minors with a jaw-dropping .399/.477/.770 line and 27 home runs over 348 PA. However, like Urias, France hasn’t done much at the big league level to this point.
  • Pirates GM Neal Huntington is seemingly leaving the door open for the club to promote one of its top prospects, third baseman Ke’Bryan Hayes, when rosters expand this Sunday. The 22-year-old hasn’t thrived overall this season in his first action at Triple-A, where he has batted .266/.334/.420 in 459 plate appearances, but he has caught fire since a slow start. Asked if the defensively adept Hayes’ recent success with the bat could lead to his first major league call-up, Huntington told Rob Biertempfel of The Athletic (subscription required), “It could in theory.” However, as you’d expect, Huntington went on to indicate the Pirates don’t want to rush him to the game’s highest level. With that in mind, Pittsburgh “probably” won’t summon Hayes to the majors this year, Biertempfel writes.
  • White Sox star Yoan Moncada has already changed positions once during his short career. After playing second base from 2017-18, he has lined up at third for the entirety of this season. While Moncada told Scott Merkin of MLB.com he expects to continue at the hot corner “for a very, very long time,” he’d be willing to move elsewhere if it helps the team. That’s unlikely to happen, per Merkin, though he notes the White Sox could do a 180 if they’re able to land, say, third baseman Anthony Rendon in free agency. In that case, Moncada could shift back to second or even the outfield – two areas that have been weak points for Chicago in 2019.

Rangers Considering Cutting Rougned Odor’s Playing Time

By | at

While it seems no such move is imminent, the Rangers are at least contemplating cutting into the playing time of second baseman Rougned Odor, reports Evan Grant of the Dallas Morning News. The 25 year-old is amidst his second dreadful season in three years.

Among qualified hitters, only Orlando Arcia has been less productive in the batters’ box than Odor, whose .197/.273/.406 slash (67 wRC+) is a far cry from the passable production he logged just last season. As the slash line indicates, Odor hasn’t had trouble hitting for power, as he’s bopped 21 home runs and posted a strong .209 ISO. Rather, he’s just given away way too many plate appearances, whether via strikeout (31.6%) or pop-up (15.6% IFFB). Odor ranks in the top ten leaguewide in both categories, with only Domingo Santana more strikeout-prone among qualifiers.

Given that lackluster performance and Odor’s similarly abysmal 2017 numbers, the organization’s patience is wearing thin. General manager Jon Daniels candidly acknowledged to Grant that “big ups and downs don’t work from a team standpoint, not when you are in the lineup every day,” and pointed out the organization has “some guys who overlap from a positional standpoint.”

Daniels clarified that his comments weren’t meant to be punitive or to put extra pressure on Odor, who both GM and manager Chris Woodward stressed has remained extremely diligent in trying to work out of the rut. That said, it’s impossible to continue to run out a player who makes as many outs as Odor has been making, and Texas does indeed have other interesting, if flawed, options.

As Grant notes, the Rangers swung a July deal with the Rays to acquire rookie second baseman Nick Solak. Amazingly, Solak’s only less than a year younger than Odor, who has been a big league mainstay for half a decade, but the rookie projects as a better hitter moving forward. Texas also has veteran Danny Santana, who has seen quite a bit of action at first base this year but profiles better at the keystone.

Whether either of those players is good enough to unseat Odor remains to be seen. Solak is a well-regarded hitting prospect but comes with a spotty at best defensive reputation, while Santana’s already 28, has a mediocre track record and has been quite BABIP-reliant in 2019. Utility prospect Eli White, meanwhile, is expected to be out for the season after suffering a shoulder injury in Triple-A.

All things considered, it seems Odor will get a little more run in Arlington. He’s starting again today, for one, and Texas’ brass continued to express optimism in his nascent ability, presumably referring to his raw power. Odor does still sport an 85th percentile hard contact rate and has 127 home runs (and counting) through his age-25 season. There are clearly still things to like about him as a player.

Nevertheless, Odor’s through over 3,000 career plate appearances with a subpar .241/.292/.435 slash (87 wRC+). He’s due another $36MM guaranteed through 2022 (with a 2023 club option) on the six-year extension he inked in March 2017, a deal that looks questionable for the team in hindsight. That price tag, while not crippling, could make an offseason trade difficult, so Texas has little recourse but to keep him on the roster. If they’re to keep running him out onto the field, though, he’ll need to tighten up his plate approach sooner rather than later.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrowsFOX Sports Engage Network scroll to top